BRCA1 and breast cancer: Thus, we conducted a qualitative study using focus groups to determine the acceptability of a PBCRA compared to standard current care in three groups of women (general population, women with a strong family history of breast cancer, and women with a BRCA1 or BRCA2 pathogenic variant), and to identify what test-specific and test-delivery factors women would take into consideration if offered a PBCRA.